Related references
Note: Only part of the references are listed.Hepatocellular carcinoma with persistent hepatitis B virus infection shows unusual downregulation of Ras expression and differential response to Ras mediated signaling
Sujoy Bose et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR
M. Caraglia et al.
CELL DEATH & DISEASE (2011)
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Gideon Bollag et al.
NATURE (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Management of advanced hepatocellular carcinoma in the era of targeted therapy
Thomas Yau et al.
LIVER INTERNATIONAL (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Drug discovery approaches targeting the PI3K/Akt pathway in cancer
C. Garcia-Echeverria et al.
ONCOGENE (2008)
The phosphoinositide 3-kinase pathway in human cancer: Genetic alterations and therapeutic implications
Alexandre Arcaro et al.
CURRENT GENOMICS (2007)
Melanoma biology and new targeted therapy
Vanessa Gray-Schopfer et al.
NATURE (2007)
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Sandrine Boyault et al.
HEPATOLOGY (2007)
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma
Ghassan K. Abou-Alfa et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma
M. Sensi et al.
ONCOGENE (2006)
Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients
Y. Tanaka et al.
ONCOGENE (2006)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Updated treatment approach to hepatocellular carcinoma
JM Llovet
JOURNAL OF GASTROENTEROLOGY (2005)
PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas
JW Lee et al.
ONCOGENE (2005)
Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma
A Tannapfel et al.
GUT (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Share Paper
